Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |